Travaux scientifiques

Prof. Dr. Salim Başol Tekin

109 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Distinguishing adrenal metastases from benign lesions in NSCLC: the value of clinical and radiological parameters

    BMC cancer, 2026

    DOI 10.1186/s12885-026-15878-7 PMID 41851668 Texte intégral en libre accèsSource : Europe PMC

  2. Prognostic Value of the Gustave Roussy Immune Score in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy: A Retrospective Cohort Study

    Diagnostics (Basel, Switzerland), 2026

    DOI 10.3390/diagnostics16121759 PMID 42351419 Texte intégral en libre accèsSource : Europe PMC

  3. Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center Study

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15124502 PMID 42355670 Texte intégral en libre accèsSource : Europe PMC

  4. Prognostic Value of Albumin-to-CEA Ratio in Metastatic Colorectal Cancer: A Retrospective Study

    Biomedicines, 2026

    DOI 10.3390/biomedicines14030579 PMID 41898226 Texte intégral en libre accèsSource : Europe PMC

  5. Parameters That May Predict NAC Effectiveness in Hormone-Positive Breast Cancer According to CPS Score

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s569515 PMID 41859752 Texte intégral en libre accèsSource : OpenAlex

  6. Adjuvant chemotherapy patterns and clinicopathological factors associated with survival in patients aged 70 years and older with resected stage II–III colon cancer: a single-center real-world study

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1959390 Texte intégral en libre accèsSource : OpenAlex

  7. Pathologist–artificial intelligence concordance in pd-l1 scoring in non-small cell lung carcinoma: a single-center validation study

    Journal of Current Pathology, 2026

    DOI 10.5146/jcpath.2026.728 Texte intégral en libre accèsSource : OpenAlex

  8. Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy

    Diagnostics (Basel, Switzerland), 2025

    DOI 10.3390/diagnostics15243158 PMID 41464158 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  9. The Relationship Between Vitamin D and Euthyroid Sick Syndrome in Hospitalized Solid Cancer Patients: A Retrospective Study

    Clinical Medicine Insights Oncology, 2025

    DOI 10.1177/11795549251359147 PMID 40735466 Texte intégral en libre accèsSource : OpenAlex

  10. New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

    Düzce Tıp Fakültesi Dergisi, 2025

    DOI 10.18678/dtfd.1637275 Texte intégral en libre accèsSource : OpenAlex

  11. Survival Comparison and Clinical Characteristics of Sunitinib and Pazopanib in the Treatment of Metastatic Renal Cell Cancer, Single Center Real-Life Data

    Kafkas Journal of Medical Sciences, 2025

    DOI 10.5505/kjms.2025.98250 Texte intégral en libre accèsSource : OpenAlex

  12. Cancer Data, Case Increase Rates and Future Prospects in the Northeastern Anatolia Region of Türkiye, a Special Region for Gastric and Esophageal Cancers in 2018-2023

    Medical Records, 2025

    DOI 10.37990/medr.1572275 Texte intégral en libre accèsSource : OpenAlex

  13. INVESTIGATION OF THE FREQUENCY OF MICROSATELLITE INSTABILITY FROM PATHOLOGICAL TISSUE SAMPLES OF PATIENTS WITH GASTRIC CANCER AND ITS EFFECT ON DISEASE PROGNOSIS AND TREATMENT

    Sabuncuoglu Serefeddin Health Sciences, 2025

    DOI 10.55895/sshs.1688217 Texte intégral en libre accèsSource : OpenAlex

  14. Inflammatory parameters in NSCLC with driver mutation

    Lung cancer management, 2024

    DOI 10.2217/lmt-2023-0014 PMID 38818368 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  15. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

    Breast Cancer: Targets and Therapy, 2024

    DOI 10.2147/bctt.s464161 PMID 38974895 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  16. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

    BMC Cancer, 2024

    DOI 10.1186/s12885-024-12347-x PMID 38783223 7 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  17. Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma

    Archives of Basic and Clinical Research, 2024

    DOI 10.5152/abcr.2024.23149 Texte intégral en libre accèsSource : OpenAlex

  18. Mide kanserinde adropin ve hipoksi ile indüklenebilir faktör -1 alfa’nın önemi

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1442369 Texte intégral en libre accèsSource : OpenAlex

  19. Investigation of Herpes Viridea and Parvovirus B19 Frequencies in Lymphopenic Malignant Patients Receiving Chemotherapy

    Van Sağlık Bilimleri Dergisi, 2024

    DOI 10.52976/vansaglik.1547450 Texte intégral en libre accèsSource : OpenAlex

  20. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer

    Future oncology (London, England), 2023

    DOI 10.2217/fon-2022-0579 PMID 37125596 8 citations (Europe PMC) Source : Europe PMC

  21. Lipegfilgrastim may cause hyperleukocytosis

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022

    DOI 10.1177/10781552221082645 PMID 35200056 1 citation (Europe PMC) Source : Europe PMC

  22. Reply to John L. Frater’s letter to the editor: Use of laboratory hematology data in melanoma research: comments on ‘A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio’

    Melanoma Research, 2022

    DOI 10.1097/cmr.0000000000000829 PMID 35703446 Source : OpenAlex

  23. The Incidences of EBV, HSV, CMV and Parvovirus B19 in the Patients with Lenfopenia Receiving Cancer Chemotherapy

    Research Square, 2022

    DOI 10.21203/rs.3.rs-1389551/v1 Texte intégral en libre accèsSource : OpenAlex

  24. The Importance of the Glucose-To-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Treated with Sorafenib

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0457 PMID 34431372 18 citations (Europe PMC) Source : OpenAlex

  25. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

    Cancer Investigation, 2021

    DOI 10.1080/07357907.2021.1933011 PMID 34014777 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  26. Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study

    The Turkish Journal of Gastroenterology, 2021

    DOI 10.5152/tjg.2021.201171 PMID 34876392 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  27. Onkolojik Aciller

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.352 Source : ORCID

  28. A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio

    Melanoma Research, 2021

    DOI 10.1097/cmr.0000000000000785 PMID 34570023 5 citations (OpenAlex) Source : OpenAlex

  29. An Atypically Located Hydatid Cyst

    Revista da Sociedade Brasileira de Medicina Tropical, 2021

    DOI 10.1590/0037-8682-0589-2020 PMID 33681925 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  30. The level of C-erbB-2 in patients with esophageal and gastric cancers

    Anatolian Current Medical Journal, 2021

    DOI 10.38053/acmj.915839 Texte intégral en libre accèsSource : OpenAlex

  31. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer

    Lung, 2020

    DOI 10.1007/s00408-020-00361-2 PMID 32424800 52 citations (OpenAlex) Source : OpenAlex

  32. The Prognostic Significance of Hemoglobin-To-Red Cell Distribution Width Ratio in Muscle-Invasive Bladder Cancer

    Biomarkers in Medicine, 2020

    DOI 10.2217/bmm-2020-0045 PMID 32648774 36 citations (OpenAlex) Source : OpenAlex

  33. Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220913081 PMID 32237958 16 citations (OpenAlex) Source : OpenAlex

  34. Clinical significance of inflammatory indexes in patients with epithelial ovarian cancer

    Acta Oncologica Turcica, 2020

    DOI 10.5505/aot.2020.38981 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  35. Rare Breast Malignancies

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2019

    DOI 10.4274/btdmjb.galenos.2019.20180815080623 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  36. Mide Kanserinde Neo-adjuvan Tedaviler

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source : OpenAlex

  37. Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results

    Medical Science and Discovery, 2019

    DOI 10.36472/msd.v6i12.330 Texte intégral en libre accèsSource : OpenAlex

  38. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma

    International Journal of Clinical Oncology, 2019

    DOI 10.1007/s10147-019-01461-7 PMID 31073814 114 citations (OpenAlex) Source : OpenAlex

  39. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study

    Irish Journal of Medical Science (1971 -), 2019

    DOI 10.1007/s11845-019-02153-x PMID 31832860 46 citations (OpenAlex) Source : OpenAlex

  40. A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII).

    PubMed, 2019

    PMID 31786885 27 citations (OpenAlex) Source : OpenAlex

  41. Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations

    International Journal of Colorectal Disease, 2019

    DOI 10.1007/s00384-019-03454-4 PMID 31845022 13 citations (OpenAlex) Source : OpenAlex

  42. Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey

    Dicle Medical Journal / Dicle Tip Dergisi, 2019

    DOI 10.5798/dicletip.579312 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  43. Single institution experience of thymoma and thymic carcinoma patients

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30257-7 Source : OpenAlex

  44. Evaluation of the effect of metoclopramide on the proliferation of human hepatocellular carcinoma Hepg2 cells

    2019

    Source : OpenAlex

  45. Immunological Agents Used in Cancer Treatment

    Eurasian Journal of Medicine, 2018

    DOI 10.5152/eurasianjmed.2018.18194 PMID 30911265 38 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  46. Relationship between 18-FDG-PET/CT and Clinicopathological Features and Pathological Responses in Patients with Locally Advanced Breast Cancers

    Eurasian Journal of Medicine, 2018

    DOI 10.5152/eurasianjmed.2018.18036 PMID 31258356 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  47. Meme Kanserinde İmmünoonkolojik Tedaviler

    Turkiye Klinikleri Medical Oncology - Special Topics, 2018

    Source : OpenAlex

  48. Kanserin İmmünolojik Tedavisinde Kullanılan Ajanlar

    Turkiye Klinikleri Medical Oncology - Special Topics, 2018

    Source : OpenAlex

  49. Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

    OncoTargets and Therapy, 2018

    DOI 10.2147/ott.s106342 PMID 29403286 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  50. P2.03-042 EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.1293 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex